Publications

5808 Results

Phase II trial of cisplatin (CP) and 5-fluorouracil (5FU) with or without allopurinol (ALL) for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: A Southwest Oncology Group study.

Authors
GR Weiss;S Green;D Stock-Novack;DS Alberts;R Giudice
Journal / Conference
ASCO 8:158(#616)
Year
1989
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8321

Evaluation of fludarabine phosphate (FLAMP) in patients with advanced mycosis fungoides (MF). A Southwest Oncology Group study.

Authors
D Von Hoff;S Dahlberg;R. Hartsock
Journal / Conference
ASCO 8:269(#1050)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8323

Increased risk of early death (ED) with high dose ara-C (HDAC)and m-AMSA compared to HDAC alone or HDAC and mitoxantrone (MITOX) inhigh risk nonlymphocytic leukemia (ANL)

Authors
C Karanes;KJ Kopecky;BGM Durie;MR Grever
Journal / Conference
ASCO 8:201(#783)
Year
1989
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8326/27

5-fluorouracil (5FU) and folinic acid (FA): for the treatment ofmetastatic gastric cancer.

Authors
JL Berenberg;PJ Goodman;N Oishi;T Fleming;RB Natale;LH Hutchins;GT Guy;J Macdonald
Journal / Conference
ASCO 8:101(#392)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8390

Carboplatin therapy in advanced endometrial cancer: A SouthwestOncology Group study.

Authors
JB Green;S Green;DS Alberts;R O'Toole;EA Surwit;JW Noltimier
Journal / Conference
ASCO 8:155(#605)
Year
1989
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8407

The treatment of non-hodgkin's lymphoma with m-BACOB,ProMACE-CytaBOM, and MACOP-B: The Southwest Oncology Group (SWOG)experience.

Authors
J Weick;S Dahlberg;T Miller;B Dana;R Fisher
Journal / Conference
ASCO 8:254(#990)
Year
1989
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508

Improved efficacy of carboplatin (CarboP)/cyclophosphamide (CPA)vs cisplatin (CisP)/CPA: Preliminary report of a phase III, randomizedtrial in stages III-IV, suboptimal ovarian cancer (OVCA).

Authors
D Alberts;S Green;E Hannigan;R O'Toole;N Mason-Liddil;E Surwit;D Stock-Novack;R Goldberg;V Malviya;W Nahhas
Journal / Conference
ASCO 8:151(#588)
Year
1989
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

A phase II study of 5-fluorouracil (5-FU) plus cisplatin (P) formetastatic colorectal adeno-carcinoma: A Southwest Oncology Groupstudy.

Authors
RP Whitehead;T Fleming;JS Macdonald;F Ahmann;M Inamasu
Journal / Conference
ASCO 8:128(#498)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8424

Significance of pre-treatment stratification by extent of disease(ED) in stage D2 prostate cancer (PC) patients treated with leuprolide +flutamide (LF) or leuprolide + placebo (LP).

Authors
M Eisenberger;ED Crawford;B Blumenstein;R Benson;D McLeod;A Dorr;J Spaulding
Journal / Conference
ASCO 8:132(#515)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036)

Phase II trial of menogaril in advanced pancreatic carcinoma:A Southwest Oncology Group trial.

Authors
T Brown;L Baker;P Goodman;T Fleming;G Fries;J Macdonald
Journal / Conference
ASCO 8:124(#481)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8513